文献速递类风湿关节炎

去乙酰化酶SIRT1对实验性关节炎滑膜血管生成及持续存在的影响

Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis.
PubMed 文献 · Ann Rheum Dis · 2020-05-07

该研究比较了类风湿关节炎(RA)患者与对照的内皮细胞表型,发现RA内皮细胞增殖更快、对TNF-α更敏感且促血管生成能力增强。微阵列分析鉴定出SIRT1表达降低,其通过p53和p65乙酰化及上调CYR61促进病理表型;内皮细胞条件性敲除SIRT1延迟实验性关节炎缓解,而SIRT1激活可逆转RA内皮细胞病理表型并减轻关节炎症状。

要点

  • RA内皮细胞SIRT1表达降低,促进增殖、凋亡敏感及促血管生成表型。
  • 内皮细胞SIRT1缺失通过p53/p65乙酰化及上调CYR61发挥作用。
  • SIRT1激活可逆转RA内皮细胞病理表型并减轻实验性关节炎。

核心结论

  • SIRT1在RA发病中发挥作用,靶向血管生成尤其是SIRT1可能作为RA的补充治疗途径。

研究设计与样本

  • 比较RA与对照的内皮细胞增殖、凋亡、对TNF-α反应及血管生成能力,并进行微阵列分析。
  • 通过小干扰RNA和腺病毒过表达在体外验证候选基因功能,并在mBSA诱导的小鼠关节炎模型中体内评估。

主要发现

  • RA内皮细胞增殖率更高、对TNF-α更敏感,体外和体内血管生成能力增强。
  • RA内皮细胞和滑膜血管中SIRT1表达降低。
  • 内皮SIRT1表达不足通过p53和p65乙酰化促进内皮细胞增殖、促凋亡及活化状态,并通过上调CYR61获得促血管生成能力。
  • 内皮细胞条件性敲除SIRT1延迟实验性mBSA诱导关节炎的缓解。
  • SIRT1激活逆转RA内皮细胞病理表型并减轻实验性mBSA诱导关节炎的体征。

临床怎么用

  • 靶向血管生成尤其是SIRT1可能作为RA的补充治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To decipher the phenotype of endothelial cells (ECs) derived from circulating progenitors issued from patients with rheumatoid arthritis (RA). METHODS: RA and control ECs were compared according to their proliferative capacities, apoptotic profile, response to tumour necrosis factor (TNF)-α stimulation and angiogenic properties. Microarray experiments were performed to identify gene candidates relevant to pathological angiogenesis. Identified candidates were detected by RT-PCR and western blot analysis in ECs and by immunohistochemistry in the synovium. Their functional relevance was then evaluated in vitro after gene invalidation by small interfering RNA and adenoviral gene overexpression, and in vivo in the mouse model of methyl-bovine serum albumin-(mBSA)-induced arthritis. RESULTS: RA ECs displayed higher proliferation rate, greater sensitisation to TNF-α and enhanced in vitro and in vivo angiogenic capacities. Microarray analyses identified the NAD-dependent protein deacetylase sirtuin-1 (SIRT1) as a relevant gene candidate. Decreased SIRT1 expression was detected in RA ECs and synovial vessels. Deficient endothelial SIRT1 expression promoted a proliferative, proapoptotic and activated state of ECs through the acetylation of p53 and p65, and lead the development of proangiogenic capacities through the upregulation of the matricellular protein cysteine-rich angiogenic protein-61. Conditional deletion of SIRT1 in ECs delayed the resolution of experimental methyl-bovine serum albumin-(mBSA)-induced arthritis. Conversely, SIRT1 activation reversed the pathological phenotype of RA ECs and alleviates signs of experimental mBSA-induced arthritis. CONCLUSIONS: These results support a role of SIRT1 in RA and may have therapeutic implications, since targeting angiogenesis, and especially SIRT1, might be used as a complementary therapeutic approach in RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Leblond A, Pezet S, Cauvet A, et al. Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis. Ann Rheum Dis. 2020. PMID: 32381568. doi:10.1136/annrheumdis-2020-217377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。